Abstract
For several years, efforts have been undertaken to increase the number of operable patients by making the diagnosis earlier in pre-symptomatic stage, in an effort to eliminate mortality.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
The National Lung Screening Trial Research Team (2011) Reduced lung cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409
Swensen SJ, Viggiano RW, Midthum DE et al (2000) Lung nodule enhancement at CT: multicentre study. Radiology 214:73–80
Tournoy KG, Keller SM, Annerma JT (2012) Mediastinal staging of lung cancer: novel concepts. Lancet Oncol 13:221–229
Gould MK, Kuschner WG, Rydzak CE et al (2003) Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small cell lung cancer, a meta-analysis. Ann Intern Med 139:879–892
Reed CE, Harpole DH, Posther KE et al (2003) Results of the American College of Surgeons Oncology Group ZOO50 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 126:1943–1951
Van Tinteron H, Hoekstra OS, Smit EF et al (2002) Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small cell lung cancer: the PLUS multicentre randomised trial. Lancet 359:1388–1392
Gu P, Zhao YZ, Juang LY et al (2009) Endobronchial ultrasound-guided Transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis. Eur J Cancer 45:1389–1396
Navani N, Brown JM, Nankivell M et al (2012) Suitability of endobronchial ultrasound-guided Transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer. A multicentre study of 774 patients. Am J Resp Crit Care Med 185:1316–1322
Skoura E, Datseris IE, Platis I et al (2012) Role of Positron Emission Tomography in the early prediction of response to chemotherapy in patients with non-small cell lung cancer. Clin Lung Cancer 13:181–187
Benamore R, Shepherd FA, Leighl N et al (2007) Does intensive follow-up alter outcome in patients with advanced lung cancer. J Thorac Oncol 2(4):273–281
Westeel V, Choma D, Clement F et al (2000) Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg 70:1185–1190
Schmidt-Hansen M, Baldwin D, Hasler E et al (2012) What is the most effective follow-up model for lung cancer patients? a systematic review. J Thorac Oncol 7(5):821–824
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
Kosmidis, P.A. (2014). Clinical Implications of Lung Cancer. In: Gouliamos, A., Andreou, J., Kosmidis, P. (eds) Imaging in Clinical Oncology. Springer, Milano. https://doi.org/10.1007/978-88-470-5385-4_27
Download citation
DOI: https://doi.org/10.1007/978-88-470-5385-4_27
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5384-7
Online ISBN: 978-88-470-5385-4
eBook Packages: MedicineMedicine (R0)